Clinical Research in the News: April 17, 2012
Over the upcoming weeks and months, one of our goals is to help our readers understand the benefits of clinical research and why it’s essential to finding cures to diseases, and the current legal and regulatory climate that makes it difficult for scientists and doctors to perform this research. Clinical research is always complex and the issues involved are sometimes difficult to understand, but everyone knows someone who is dealing with an illness, or is personally dealing with an illness themselves, so this is an essential topic to discuss.
- Yesterday, the Wall Street Journal wrote about frustrated ALS (Lou Gerhig’s disease) patients that are brewing their own medications because they can’t afford to wait for new FDA approved drugs. This is a must read.
- Also yesterday, Dr. DeFelice wrote an article about the restrictive FDA clinical testing process and how a reform of this process would increase the possibility for finding cures.
- Allen Frances wrote a piece for the Huffington Post about people at risk of psychosis and had an interesting perspective on the unfortunate reality that most clinical research doesn’t have an effect on clinical practices – even though it sometimes should.
- In non-medical clinical research, a UCLA professor took eHarmony to task for their unscientific process that dupes customers.
We’ll have more clinical research news several times a week, with additional commentaries and efforts to try to get at the root of why clinical research isn’t understood or appreciated.